|Day Low/High||28.65 / 29.13|
|52 Wk Low/High||/|
Where it began. The bulls will be focused on the benefit of continued low interest rates and its salutary impact on stock valuations. Question: Should market P/E trend higher based on ever easy central bank that brings a lower-than-historical level ...
Portfolio Manager Bryan Ashenberg says EMC is under-appreciated on Wall Street and is undervalued when backing out the company's VMware stake and cash position.
Despite the recent hand-wringing, we are still in a bull market.
These stocks and sectors are still reasonably priced, given their growth prospects.
The demand for storage is greater than ever due to increased regulatory requirements and internet usage, which is why EMC remains a stock worth owning.
Yahoo! CEO Marissa Mayer is facing a little more heat as advertising sales disappointed for the search and media company. Jonathan Marino reports from the Nasdaq Marketsite.
Here are some early looks. Its a big rebalancing today. Below are some early looks: General Electric (GE) -- 2 million to sell, 3 million paired off. Bank of America (BAC) -- 2 million to sell, 3 million paired off. Pfizer (PFE) -- 2 million to sell...
Here's a whole new crop of stocks that I think can beat next year's market.
Today's loss fills an important gap, and a bottom should quietly form in the next two weeks.
How much to buy? My mavens on the floor of the exchange see only about $135 million to buy on the close. Financials have $110 million to buy and health care has $40 million to buy. Johnson & Johnson (JNJ) has $50 million to buy, Franklin Resources (...
Let's take a peek at overnight and early-morning price action in some of the major asset classes. The rundown: S&P futures +5; Nasdaq +24, as Apple (AAPL) moves in after-hours trading; Nikkei -; European markets +; crude flat; gold +$5; and 10-year ...
How much to buy? My mavens on the floor of the exchange see $700 million to buy on the close. Health care has $240 million and financials has $175 million to buy. Johnson & Johnson (JNJ) has a large buy order of $160 million, and Bristol-Myers Squib...